Advertisement
Advertisement

TBPH

TBPH logo

Theravance Biopharma, Inc.

11.05
USD
-0.02
-0.18%
Jul 31, 11:50 UTC -4
Open

Theravance Biopharma, Inc. Profile

Info & Links

CEO

Rick E Winningham

Headquarters

901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CA 94080, UNITED STATES

Sector

Medical

Auditor

Ernst & Young LLP

Share holders

39

Employees

97

Theravance Biopharma, Inc. Statistics

Valuation Measures

Market Capitalization2

552.51M

Enterprise Value

441.90M

Enterprise Value/EBITDA(ttm)

-8.67

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-90.56%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-32.40%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

65.27M

Revenue Per Share(ttm)

1.31

Gross Profit(ttm)

65.27M

EBITDA(ttm)3

-50.97M

Net Income Available to Common(ttm)

-58.33M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

9.84%

S&P 500 52-Week Change

15.68%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

50.00M

Dividend Yield

--

Float4

--

% Held by Insiders

--

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

130.85M

Total Cash Per Share(mrq)

2.62

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.77%

Quick Ratio(mrq)

--

Book Value Per Share(mrq)

3.32

Cash Flow

Operating Cash Flow Per Share(ytd)

0.87

Free Cash Flow(ytd)

43.04M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement